Characterization of biopharmaceutical erythropoietin (rhEPO) by glycoproteomic approach – from peptide mapping to released N-glycans

Key Points

• The aim is to analyze erythropoietin using glycoproteomic methods to understand its structure and function.
• Utilized glycoproteomic approaches for analysis
• Conducted peptide mapping of erythropoietin
• Examined released N-glycans derived from the erythropoietin
• Characterized unique glycan structures in erythropoietin
• Identified specific peptide profiles related to glycosylation
• Enhanced understanding of erythropoietin's functional implications in biopharmaceuticals

Abstract